All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Neoplasms-38970084

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38970084	A164V	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
2	38970084	A5520G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
3	38970084	A5580G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
4	38970084	A5774C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
5	38970084	A5832C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
6	38970084	A5924C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
7	38970084	A6125G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
8	38970084	A6401G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
9	38970084	A6404G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
10	38970084	A6430C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
11	38970084	A6878C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
12	38970084	A6970C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
13	38970084	A7045C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
14	38970084	C5769T	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
15	38970084	C5875A	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
16	38970084	C5920T	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
17	38970084	C7062T	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
18	38970084	E498K	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
19	38970084	G5503A	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
20	38970084	G6921A	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
21	38970084	K514T	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
22	38970084	K539T	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
23	38970084	P114S	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
24	38970084	Q334P	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
25	38970084	R25Q	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
26	38970084	R51G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
27	38970084	R545C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
28	38970084	S31G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
29	38970084	T149N	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
30	38970084	T5882C	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
31	38970084	T5942G	L1	L1	Uterine Cervical Neoplasms	G R S C L	View
32	38970084	C751T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
33	38970084	C835T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
34	38970084	G747A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
35	38970084	R53Q	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
36	38970084	A482C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
37	38970084	C549A	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
38	38970084	S82A	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
39	38970084	T348G	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
40	38970084	T392C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
41	38970084	T467G	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
42	38970084	T485C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.